Employee Benefits News examines legal developments that impact the employee benefits and executive compensation employers provide, including federal and state legislation, rules from federal...
The retirement plan committee of International Business Machines Corp. and its executives again defeated a lawsuit accusing them of failing to mitigate a “foreseeable drop” in the company’s stock and protect participants from losing millions of dollars in retirement savings ( Jander v. Ret. Plans Comm. of IBM , 2017 BL 346271, S.D.N.Y., No. 1:15-cv-03781-WHP, motion to dismiss granted 9/29/17 ).
The participants offered three alternative actions IBM and the executives could’ve taken to mitigate the risks to the plan, but this wasn’t enough to support a fiduciary breach claim, a federal judge in New York held Sept. 29. Those three alternative actions included issuing a corrective disclosure earlier, halting all purchases and sales of IBM stock, and purchasing a hedging product.
The decision comes almost a year after the same judge—William H. Pauley III of the U.S. District Court for the Southern District of New York— dismissed the participants’ lawsuit for the first time. In that ruling, Pauley said the participants didn’t allege facts inferring that IBM couldn’t have concluded that public disclosures or halting the plan from further investing in IBM stock were more likely to harm than help the plan.
Employees challenging losses in their retirement savings as a result of company stock drops are consistently losing in court. This is due to a 2014 U.S. Supreme Court decision that heightened the pleading standard for claims of breach of fiduciary duty of prudence on the basis of inside information under the Employee Retirement Income Security Act.
Since then, a growing list of companies have defeated such lawsuits, including WellsFargo Co., Target Corp., Cliffs Natural Resources Inc., Reliance Trust Co., Lehman Brothers Holdings Inc., State Street Bank & Trust Co., RadioShack, Citigroup, Eaton Corp., Whole Foods Corp., JPMorgan Chase & Co., and BP Plc.
The participants accused IBM executives of artificially inflating the value of the company’s stock by issuing misleading financial statements related to its microelectronics business.
Pauley rejected the participants’ claim that an earlier disclosure could have ended the artificial inflation. While the allegations were plausible on a theoretical basis, they fail to shed light on whether a prudent fiduciary in the executives’ position under circumstances then prevailing believed that a corrective disclosure wouldn’t have done more harm than good to the plan, Pauley said.
As to halting trades, Pauley said that participants overlooked the possibility that this action “could send mixed signals,” such as diminished confidence in IBM stock, causing a drop in stock price that could have done more harm than good to the plan.
Rejecting the participants’ alternative action of purchasing a low-cost hedging product, Pauley said they failed to give consideration to the costs that could have been incurred from taking this action. He also pointed out that obtaining this kind of product may have required disclosure under ERISA.
Zamansky LLC represents the participants. Davis Polk & Wardwell LLP represents the committee and the executives.
To contact the reporter on this story: Carmen Castro-Pagan in Washington at email@example.com
To contact the editor responsible for this story: Jo-el J. Meyer at firstname.lastname@example.org
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)